Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced non-small-cell lung cancer patients treated with concurrent chemoradiotherapy: a comparison of photon and proton radiation therapy.

Rice SR, Saboury B, Houshmand S, Salavati A, Kalbasi A, Goodman CR, Werner TJ, Vujaskovic Z, Simone CB 2nd, Alavi A.

Nucl Med Commun. 2019 Jun;40(6):618-625. doi: 10.1097/MNM.0000000000000997.

PMID:
31095527
2.

Reinventing Radiology: Big Data and the Future of Medical Imaging.

Morris MA, Saboury B, Burkett B, Gao J, Siegel EL.

J Thorac Imaging. 2018 Jan;33(1):4-16. doi: 10.1097/RTI.0000000000000311. Review.

PMID:
29252898
3.

Feature analysis of ultrasound elastography image for quantitative assessment of cutaneous carcinoma.

Morris MA, Ring CM, Managuli R, Saboury B, Mehregan D, Siegel E, Dasgeb B.

Skin Res Technol. 2018 May;24(2):242-247. doi: 10.1111/srt.12420. Epub 2017 Oct 25.

PMID:
29067713
4.

Finding the sweet spot for metformin in 18F-FDG-PET.

Morris M, Saboury B, Chen W, Siegel EL, Dasgeb B.

Nucl Med Commun. 2017 Oct;38(10):875-880. doi: 10.1097/MNM.0000000000000728.

PMID:
28800002
5.

Prognostic Predictors of Visual Outcome in Open Globe Injury: Emphasis on Facial CT Findings.

Bodanapally UK, Addis H, Dreizin D, Reddy AK, Margo JA, Archer-Arroyo KL, Feldman S, Saboury B, Sudini K, Saeedi O.

AJNR Am J Neuroradiol. 2017 May;38(5):1013-1018. doi: 10.3174/ajnr.A5107. Epub 2017 Mar 16.

6.

Computer-Aided Reporting of Chest Radiographs: Efficient and Effective Screening in the Value-Based Imaging Era.

Morris M, Saboury B, Bandla N, Toland C, Meenan C, Siegel E, Jeudy J.

J Digit Imaging. 2017 Oct;30(5):589-594. doi: 10.1007/s10278-017-9952-y.

7.

Quantitative normal thoracic anatomy at CT.

Matsumoto MM, Udupa JK, Tong Y, Saboury B, Torigian DA.

Comput Med Imaging Graph. 2016 Jul;51:1-10. doi: 10.1016/j.compmedimag.2016.03.005. Epub 2016 Apr 1.

PMID:
27065241
8.

Quantification of aging effects upon global knee inflammation by 18F-FDG-PET.

Saboury B, Parsons MA, Moghbel M, Rubello D, Brothers A, Torigian DA, Werner TJ, Houshmand S, Basu S, Lam MG, Alavi A.

Nucl Med Commun. 2016 Mar;37(3):254-8. doi: 10.1097/MNM.0000000000000430.

PMID:
26555103
9.

Increased 18F-FDG uptake suggests synovial inflammatory reaction with osteoarthritis: preliminary in-vivo results in humans.

Parsons MA, Moghbel M, Saboury B, Torigian DA, Werner TJ, Rubello D, Basu S, Alavi A.

Nucl Med Commun. 2015 Dec;36(12):1215-9. doi: 10.1097/MNM.0000000000000376.

10.

A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography.

deGoma EM, Salavati A, Shinohara RT, Saboury B, Pollan L, Schoen M, Torigian DA, Mohler ER, Dunbar RL, Litt HI, Woo J, Rader DJ, Alavi A, Mehta NN.

Acad Radiol. 2015 May;22(5):600-9. doi: 10.1016/j.acra.2014.12.015. Epub 2015 Feb 21.

PMID:
25708866
11.

Feasibility and performance of an adaptive contrast-oriented FDG PET/CT quantification technique for global disease assessment of malignant pleural mesothelioma and a brief review of the literature.

Marin-Oyaga VA, Salavati A, Houshmand S, Pasha AK, Gharavi M, Saboury B, Basu S, Torigian DA, Alavi A.

Hell J Nucl Med. 2015 Jan-Apr;18(1):11-8. doi: 10.1967/s002449910162. Epub 2015 Feb 13. Review.

12.

Effects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteries.

Pasha AK, Moghbel M, Saboury B, Gharavi MH, Blomberg BA, Torigian DA, Kwee TC, Basu S, Mohler Iii ER, Alavi A.

Hell J Nucl Med. 2015 Jan-Apr;18(1):5-10. doi: 10.1967/s002449910161. Epub 2015 Feb 13.

13.

Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesions.

Salavati A, Borofsky S, Boon-Keng TK, Houshmand S, Khiewvan B, Saboury B, Codreanu I, Torigian DA, Zaidi H, Alavi A.

Mol Imaging Biol. 2015 Feb;17(1):140-8. doi: 10.1007/s11307-014-0776-6.

PMID:
25080325
14.

Role of (18)F-fluorodeoxyglucose positron emission tomography imaging in the management of primary cutaneous lymphomas.

Spaccarelli N, Gharavi M, Saboury B, Cheng G, Rook AH, Alavi A.

Hell J Nucl Med. 2014 May-Aug;17(2):78-84. doi: 10.1967/s002449910131. Epub 2014 Jul 5. Review.

15.

FDG PET for diagnosing infection in hip and knee prostheses: prospective study in 221 prostheses and subgroup comparison with combined (111)In-labeled leukocyte/(99m)Tc-sulfur colloid bone marrow imaging in 88 prostheses.

Basu S, Kwee TC, Saboury B, Garino JP, Nelson CL, Zhuang H, Parsons M, Chen W, Kumar R, Salavati A, Werner TJ, Alavi A.

Clin Nucl Med. 2014 Jul;39(7):609-15. doi: 10.1097/RLU.0000000000000464.

16.

Body-wide hierarchical fuzzy modeling, recognition, and delineation of anatomy in medical images.

Udupa JK, Odhner D, Zhao L, Tong Y, Matsumoto MM, Ciesielski KC, Falcao AX, Vaideeswaran P, Ciesielski V, Saboury B, Mohammadianrasanani S, Sin S, Arens R, Torigian DA.

Med Image Anal. 2014 Jul;18(5):752-71. doi: 10.1016/j.media.2014.04.003. Epub 2014 Apr 24.

17.

Skin Prick Test Reactivity to Common Aero and Food Allergens among Children with Allergy.

Hosseini S, Shoormasti RS, Akramian R, Movahedi M, Gharagozlou M, Foroughi N, Saboury B, Kazemnejad A, Mahlooji Rad M, Mahdaviani A, Pourpak Z, Moin M.

Iran J Med Sci. 2014 Jan;39(1):29-35.

18.

Comment on: "Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT".

Salavati A, Saboury B, Alavi A.

J Nucl Med. 2014 Feb;55(2):350-1. doi: 10.2967/jnumed.113.130138. Epub 2013 Dec 9. No abstract available.

19.

Assessment of global cardiac uptake of radiolabeled iron oxide nanoparticles in apolipoprotein-E-deficient mice: implications for imaging cardiovascular inflammation.

de Barros AL, Chacko AM, Mikitsh JL, Al Zaki A, Salavati A, Saboury B, Tsourkas A, Alavi A.

Mol Imaging Biol. 2014 Jun;16(3):330-9. doi: 10.1007/s11307-013-0709-9.

20.

FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity.

Saboury B, Salavati A, Brothers A, Basu S, Kwee TC, Lam MG, Hustinx R, Louis E, Torigian DA, Alavi A.

Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):605-14. doi: 10.1007/s00259-013-2625-2. Epub 2013 Nov 20.

PMID:
24253895
21.

A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot study.

Rose S, Sheth NH, Baker JF, Ogdie A, Raper A, Saboury B, Werner TJ, Thomas P, Vanvoorhees A, Alavi A, Torigian DA, Gelfand JM, Mehta NN.

Am J Cardiovasc Dis. 2013 Nov 1;3(4):273-8. eCollection 2013.

22.

Quantitative assessment of global hepatic glycolysis in patients with cirrhosis and normal controls using 18F-FDG-PET/CT: a pilot study.

Hernandez-Martinez A, Marin-Oyaga VA, Salavati A, Saboury B, Codreanu I, Lam MG, Torigian DA, Alavi A.

Ann Nucl Med. 2014 Jan;28(1):53-9. doi: 10.1007/s12149-013-0780-y. Epub 2013 Oct 27.

PMID:
24163174
23.

Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study.

Abdulla S, Salavati A, Saboury B, Basu S, Torigian DA, Alavi A.

Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):350-6. doi: 10.1007/s00259-013-2579-4. Epub 2013 Oct 2.

PMID:
24085504
24.

A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma.

Beatty GL, Torigian DA, Chiorean EG, Saboury B, Brothers A, Alavi A, Troxel AB, Sun W, Teitelbaum UR, Vonderheide RH, O'Dwyer PJ.

Clin Cancer Res. 2013 Nov 15;19(22):6286-95. doi: 10.1158/1078-0432.CCR-13-1320. Epub 2013 Aug 27.

25.

Delayed time-point 18F-FDG PET CT imaging enhances assessment of atherosclerotic plaque inflammation.

Blomberg BA, Akers SR, Saboury B, Mehta NN, Cheng G, Torigian DA, Lim E, Del Bello C, Werner TJ, Alavi A.

Nucl Med Commun. 2013 Sep;34(9):860-7. doi: 10.1097/MNM.0b013e3283637512.

PMID:
23799532
26.

Adverse functional effects of chemotherapy on whole-brain metabolism: a PET/CT quantitative analysis of FDG metabolic pattern of the "chemo-brain".

Sorokin J, Saboury B, Ahn JA, Moghbel M, Basu S, Alavi A.

Clin Nucl Med. 2014 Jan;39(1):e35-9. doi: 10.1097/RLU.0b013e318292aa81.

PMID:
23751834
27.

Role of FDG PET/CT in investigating the mechanisms underlying atherosclerotic plaque formation and evolution.

Marzola MC, Saboury B, Chondrogiannis S, Rampin L, Grassetto G, Ferretti A, Alavi A, Rubello D.

Rev Esp Med Nucl Imagen Mol. 2013 Jul-Aug;32(4):246-52. doi: 10.1016/j.remn.2013.04.001. Epub 2013 May 30. Review.

PMID:
23726249
28.

Assessment of the diagnostic performance of (18)F-FDG-PET/CT for detection and characterization of solid renal malignancies.

Nakhoda Z, Torigian DA, Saboury B, Hofheinz F, Alavi A.

Hell J Nucl Med. 2013 Jan-Apr;16(1):19-24. doi: 10.1967/s002449910067. Epub 2013 Mar 26.

29.

In vivo quantification of pulmonary inflammation in relation to emphysema severity via partial volume corrected (18)F-FDG-PET using computer-assisted analysis of diagnostic chest CT.

Torigian DA, Dam V, Chen X, Saboury B, Udupa JK, Rashid A, Moghadam-Kia S, Alavi A.

Hell J Nucl Med. 2013 Jan-Apr;16(1):12-8. doi: 10.1967/s0024499100066. Epub 2013 Mar 26.

30.

PET/MR imaging: technical aspects and potential clinical applications.

Torigian DA, Zaidi H, Kwee TC, Saboury B, Udupa JK, Cho ZH, Alavi A.

Radiology. 2013 Apr;267(1):26-44. doi: 10.1148/radiol.13121038. Review.

PMID:
23525716
31.

The effect of breathing irregularities on quantitative accuracy of respiratory gated PET∕CT.

Teo BK, Saboury B, Munbodh R, Scheuermann J, Torigian DA, Zaidi H, Alavi A.

Med Phys. 2012 Dec;39(12):7390-7. doi: 10.1118/1.4766876.

PMID:
23231288
32.

Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot study.

Yu Y, Sheth N, Krishnamoorthy P, Saboury B, Raper A, Baer A, Ochotony R, Doveikis J, Derohannessian S, Voorhees AS, Torigian DA, Alavi A, Gelfand JM, Mehta NN.

Am J Cardiovasc Dis. 2012;2(4):285-92. Epub 2012 Oct 23.

33.

Age-related inflammatory changes in the spine as demonstrated by (18)F-FDG-PET:observation and insight into degenerative spinal changes.

Aliyev A, Saboury B, Kwee TC, Torigian DA, Basu S, Wulff Christensen H, Alavi A.

Hell J Nucl Med. 2012 Sep-Dec;15(3):197-201. doi: 10.1967/s002449910054. Epub 2012 Oct 25.

34.

Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease.

Musiek ES, Saboury B, Mishra S, Chen Y, Reddin JS, Newberg AB, Udupa JK, Detre JA, Hofheinz F, Torigian D, Alavi A.

Hell J Nucl Med. 2012 Sep-Dec;15(3):190-6. doi: 10.1967/s002449910052. Epub 2012 Oct 25.

35.

β-Cell mass imaging with DTBZ positron emission tomography: is it possible?

Blomberg BA, Eriksson O, Saboury B, Alavi A.

Mol Imaging Biol. 2013 Feb;15(1):1-2. doi: 10.1007/s11307-012-0593-8. No abstract available.

PMID:
22983914
36.

Emerging role of radiolabeled nanoparticles as an effective diagnostic technique.

de Barros AB, Tsourkas A, Saboury B, Cardoso VN, Alavi A.

EJNMMI Res. 2012 Jul 18;2(1):39. doi: 10.1186/2191-219X-2-39.

37.

The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis.

Blomberg BA, Moghbel MC, Saboury B, Stanley CA, Alavi A.

Mol Imaging Biol. 2013 Feb;15(1):97-105. doi: 10.1007/s11307-012-0572-0. Review.

38.

Relation between popliteal-tibial artery atherosclerosis and global glycolytic metabolism in the affected diabetic foot: a pilot study using quantitative FDG-PET.

Nawaz A, Saboury B, Basu S, Zhuang H, Moghadam-Kia S, Werner T, Mohler ER 3rd, Torigian DA, Alavi A.

J Am Podiatr Med Assoc. 2012 May-Jun;102(3):240-6.

PMID:
22659767
39.
40.

Promising Roles of PET in Management of Arthroplasty-Associated Infection.

Saboury B, Ziai P, Parsons M, Zhuang H, Basu S, Alavi A.

PET Clin. 2012 Apr;7(2):139-50. doi: 10.1016/j.cpet.2012.01.002.

PMID:
27157232
41.

Functional oncoimaging techniques with potential clinical applications.

Kwee TC, Basu S, Saboury B, Alavi A, Torigian DA.

Front Biosci (Elite Ed). 2012 Jan 1;4:1081-96. Review.

PMID:
22201938
42.

Reduced grey matter metabolism due to white matter edema allows optimal assessment of brain tumors on 18F-FDG-PET.

Pourdehnad M, Basu S, Duarte P, Okpaku AS, Saboury B, Hustinx R, Alavi A.

Hell J Nucl Med. 2011 Sep-Dec;14(3):219-23.

43.

Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.

Musiek ES, Chen Y, Korczykowski M, Saboury B, Martinez PM, Reddin JS, Alavi A, Kimberg DY, Wolk DA, Julin P, Newberg AB, Arnold SE, Detre JA.

Alzheimers Dement. 2012 Jan;8(1):51-9. doi: 10.1016/j.jalz.2011.06.003. Epub 2011 Oct 21.

44.

Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies?

Moghbel MC, Saboury B, Basu S, Metzler SD, Torigian DA, Långström B, Alavi A.

Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):202-8. doi: 10.1007/s00259-011-1960-4. No abstract available.

PMID:
22009379
45.

Role of Global Disease Assessment by Combined PET-CT-MR Imaging in Examining Cardiovascular Disease.

Saboury B, Ziai P, Alavi A.

PET Clin. 2011 Oct;6(4):421-9. doi: 10.1016/j.cpet.2011.10.003. Epub 2011 Nov 24.

PMID:
27156877
46.

Detection and Quantification of Molecular Calcification by PET/Computed Tomography: A New Paradigm in Assessing Atherosclerosis.

Saboury B, Ziai P, Alavi A.

PET Clin. 2011 Oct;6(4):409-15. doi: 10.1016/j.cpet.2011.10.001. Epub 2011 Nov 24.

PMID:
27156875
47.

Imaging the infected heart.

Alavi A, Saboury B, Basu S.

Sci Transl Med. 2011 Sep 7;3(99):99fs3. doi: 10.1126/scitranslmed.3003044.

PMID:
21900589
48.

Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography--a novel concept.

Beheshti M, Saboury B, Mehta NN, Torigian DA, Werner T, Mohler E, Wilensky R, Newberg AB, Basu S, Langsteger W, Alavi A.

Hell J Nucl Med. 2011 May-Aug;14(2):114-20.

49.

Evolving role of FDG PET imaging in assessing joint disorders: a systematic review.

Carey K, Saboury B, Basu S, Brothers A, Ogdie A, Werner T, Torigian DA, Alavi A.

Eur J Nucl Med Mol Imaging. 2011 Oct;38(10):1939-55. doi: 10.1007/s00259-011-1863-4. Epub 2011 Jul 14. Review.

PMID:
21755370
50.

Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.

Mehta NN, Yu Y, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, Gelfand JM.

Arch Dermatol. 2011 Sep;147(9):1031-9. doi: 10.1001/archdermatol.2011.119. Epub 2011 May 16.

Supplemental Content

Loading ...
Support Center